Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

@article{Bertrand2014CancerNT,
  title={Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.},
  author={Nicolas Bertrand and Jun Wu and Xiaoyang Xu and Nazila Kamaly and Omid C Farokhzad},
  journal={Advanced drug delivery reviews},
  year={2014},
  volume={66},
  pages={2-25}
}
Cancer nanotherapeutics are progressing at a steady rate; research and development in the field has experienced an exponential growth since early 2000's. The path to the commercialization of oncology drugs is long and carries significant risk; however, there is considerable excitement that nanoparticle technologies may contribute to the success of cancer drug development. The pace at which pharmaceutical companies have formed partnerships to use proprietary nanoparticle technologies has… CONTINUE READING
Highly Influential
This paper has highly influenced 17 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
328 Citations
341 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 328 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 341 references

Similar Papers

Loading similar papers…